Article Details

AbbVie's atogepant, Biohaven's Nurtec ODT for preventive migraine unlikely to cause approved ...

Retrieved on: 2021-04-26 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

AbbVie's atogepant, Biohaven's Nurtec ODT for preventive migraine unlikely to cause approved .... View article details on hiswai:

Excerpt

... for AbbVie's atogepant and Biohaven Pharmaceuticals' Nurtec ODT (rimegepant) for preventive migraine, approved monoclonal antibodies (mAbs) ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up